TY - JOUR
T1 - Optimised molecular genetic diagnostics of Fanconi anaemia by whole exome sequencing and functional studies
AU - Bogliolo, Massimo
AU - Pujol, Roser
AU - Aza-Carmona, Miriam
AU - Muñoz-Subirana, Núria
AU - Rodriguez-Santiago, Benjamin
AU - Casado, José Antonio
AU - Rio, Paula
AU - Bauser, Christopher
AU - Reina-Castillón, Judith
AU - Lopez-Sanchez, Marcos
AU - Gonzalez-Quereda, Lidia
AU - Gallano, Pia
AU - Catalá, Albert
AU - Ruiz-Llobet, Ana
AU - Badell, Isabel
AU - Diaz-Heredia, Cristina
AU - Hladun, Raquel
AU - Senent, Leonort
AU - Argiles, Bienvenida
AU - Bergua Burgues, Juan Miguel
AU - Bañez, Fatima
AU - Arrizabalaga, Beatriz
AU - López Almaraz, Ricardo
AU - Lopez, Monica
AU - Figuera, Ángela
AU - Molinés, Antonio
AU - Pérez De Soto, Inmaculada
AU - Hernando, Inés
AU - Muñoz, Juan Antonio
AU - Del Rosario Marin, Maria
AU - Balmaña, Judith
AU - Stjepanovic, Neda
AU - Carrasco, Estela
AU - Cuesta, Isabel
AU - Cosuelo, José Miguel
AU - Regueiro, Alexandra
AU - Moraleda Jimenez, José
AU - Galera-Miñarro, Ana Maria
AU - Rosiñol, Laura
AU - Carrió, Anna
AU - Beléndez-Bieler, Cristina
AU - Escudero Soto, Antonio
AU - Cela, Elena
AU - De La Mata, Gregorio
AU - Fernández-Delgado, Rafael
AU - Garcia-Pardos, Maria Carmen
AU - Sáez-Villaverde, Raquel
AU - Barragaño, Marta
AU - Portugal, Raquel
AU - Lendinez, Francisco
AU - Hernadez, Ines
AU - Vagace, José Manue
AU - Tapia, Maria
AU - Nieto, José
AU - Garcia, Marta
AU - Gonzalez, Macarena
AU - Vicho, Cristina
AU - Galvez, Eva
AU - Valiente, Alberto
AU - Antelo, Maria Luisa
AU - Ancliff, Phil
AU - Garcia, Francisco
AU - Dopazo, Joaquin
AU - Sevilla, Julian
AU - Paprotka, Tobias
AU - Pérez-Jurado, Luis Alberto
AU - Bueren, Juan
AU - Surralles, Jordi
N1 - © Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.
PY - 2019/1/1
Y1 - 2019/1/1
N2 - © Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ. Purpose: Patients with Fanconi anaemia (FA), a rare DNA repair genetic disease, exhibit chromosome fragility, bone marrow failure, malformations and cancer susceptibility. FA molecular diagnosis is challenging since FA is caused by point mutations and large deletions in 22 genes following three heritability patterns. To optimise FA patients' characterisation, we developed a simplified but effective methodology based on whole exome sequencing (WES) and functional studies. Methods: 68 patients with FA were analysed by commercial WES services. Copy number variations were evaluated by sequencing data analysis with RStudio. To test FANCA missense variants, wt FANCA cDNA was cloned and variants were introduced by site-directed mutagenesis. Vectors were then tested for their ability to complement DNA repair defects of a FANCA-KO human cell line generated by TALEN technologies. Results: We identified 93.3% of mutated alleles including large deletions. We determined the pathogenicity of three FANCA missense variants and demonstrated that two FANCA variants reported in mutations databases as 'affecting functions' are SNPs. Deep analysis of sequencing data revealed patients' true mutations, highlighting the importance of functional analysis. In one patient, no pathogenic variant could be identified in any of the 22 known FA genes, and in seven patients, only one deleterious variant could be identified (three patients each with FANCA and FANCD2 and one patient with FANCE mutations) Conclusion: WES and proper bioinformatics analysis are sufficient to effectively characterise patients with FA regardless of the rarity of their complementation group, type of mutations, mosaic condition and DNA source.
AB - © Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ. Purpose: Patients with Fanconi anaemia (FA), a rare DNA repair genetic disease, exhibit chromosome fragility, bone marrow failure, malformations and cancer susceptibility. FA molecular diagnosis is challenging since FA is caused by point mutations and large deletions in 22 genes following three heritability patterns. To optimise FA patients' characterisation, we developed a simplified but effective methodology based on whole exome sequencing (WES) and functional studies. Methods: 68 patients with FA were analysed by commercial WES services. Copy number variations were evaluated by sequencing data analysis with RStudio. To test FANCA missense variants, wt FANCA cDNA was cloned and variants were introduced by site-directed mutagenesis. Vectors were then tested for their ability to complement DNA repair defects of a FANCA-KO human cell line generated by TALEN technologies. Results: We identified 93.3% of mutated alleles including large deletions. We determined the pathogenicity of three FANCA missense variants and demonstrated that two FANCA variants reported in mutations databases as 'affecting functions' are SNPs. Deep analysis of sequencing data revealed patients' true mutations, highlighting the importance of functional analysis. In one patient, no pathogenic variant could be identified in any of the 22 known FA genes, and in seven patients, only one deleterious variant could be identified (three patients each with FANCA and FANCD2 and one patient with FANCE mutations) Conclusion: WES and proper bioinformatics analysis are sufficient to effectively characterise patients with FA regardless of the rarity of their complementation group, type of mutations, mosaic condition and DNA source.
KW - clinical genetics
KW - genetics
KW - haematology (incl blood transfusion)
UR - http://www.mendeley.com/research/optimised-molecular-genetic-diagnostics-fanconi-anaemia-whole-exome-sequencing-functional-studies
U2 - 10.1136/jmedgenet-2019-106249
DO - 10.1136/jmedgenet-2019-106249
M3 - Article
C2 - 31586946
SN - 0022-2593
JO - Journal of Medical Genetics
JF - Journal of Medical Genetics
ER -